Copy Number
The putative cancer-associated PDGs driven by SCNAs in each cancer type were identified by four criteria: 1) located in a peak region of a significantly recurrent focal SNCA locus estimated by the genomic identification of significant targets in cancer (GISTIC2) algorithm, (q≤0.25); 2) altered with high frequency and large amplitude (G-score ≥0.1); 3) mRNA reliably detected in at least 10% of tumor specimens in the given cancer type (90th percentile of FPKM value ≥1); and 4) mRNA significantly and positively correlated with copy numbers (Pearson P-value less than 0.001).
| Showing page 45 |
first page | previous page | next page | last page |
| Overall_Gscore | No. of Cancer Types | ||||
| HGNC Symbol | Ensembl Gene ID | Amplification | Deletion | Amplification | Deletion |
| GFER | ENSG00000127554 | 0.00 | 0.00 | 0 | 0 |
| WFIKKN1 | ENSG00000127578 | 0.00 | 0.14 | 0 | 1 |
| OR1E2 | ENSG00000127780 | 0.00 | 0.00 | 0 | 0 |
| TUBA4A | ENSG00000127824 | 0.00 | 0.37 | 0 | 2 |
| FGL2 | ENSG00000127951 | 0.00 | 0.00 | 0 | 0 |
| SRD5A3 | ENSG00000128039 | 0.73 | 0.00 | 3 | 0 |
| SPINK2 | ENSG00000128040 | 0.00 | 0.00 | 0 | 0 |
| KDR | ENSG00000128052 | 0.12 | 0.00 | 1 | 0 |
| ADM2 | ENSG00000128165 | 0.00 | 1.19 | 0 | 4 |
| ADORA2A | ENSG00000128271 | 0.00 | 0.00 | 0 | 0 |
| MCHR1 | ENSG00000128285 | 0.00 | 0.00 | 0 | 0 |
| GALR3 | ENSG00000128310 | 0.00 | 0.00 | 0 | 0 |
| TST | ENSG00000128311 | 0.00 | 0.00 | 0 | 0 |
| IGLL1 | ENSG00000128322 | 0.00 | 0.00 | 0 | 0 |
| LIF | ENSG00000128342 | 0.14 | 0.00 | 1 | 0 |
| APOBEC3A | ENSG00000128383 | 0.00 | 0.00 | 0 | 0 |
| CPA4 | ENSG00000128510 | 0.00 | 0.00 | 0 | 0 |
| TAS2R16 | ENSG00000128519 | 0.00 | 0.00 | 0 | 0 |
| VGF | ENSG00000128564 | 0.00 | 0.00 | 0 | 0 |
| LRRC4 | ENSG00000128594 | 0.00 | 0.00 | 0 | 0 |
|
Showing page 45 |
first page | previous page | next page | last page |
Copyright © 2020 University of Pennsylvania. All Rights Reserved.